Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database

References

• Ten Doesschate J. Causes of blindness in The Netherlands. Doc Ophthalmol. 1982;52(3–4):279–285. doi:10.1007/BF01675857.
   PubMed Web of Science ®Google Scholar
• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844–848. doi:10.1136/bjo.80.9.844.
   PubMed Web of Science ®Google Scholar
• Subcommittee NAECPP. Vision Research A national plan: 1983-1987: volume 1: the 1983 report of the national advisory eye council. National Institutes of Health, Public Health Service, US Department of Health and Human Services, Bethesda, MD. 1983:13.
   Google Scholar
• Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14(5–6):303–308. doi:10.1007/BF00163549.
   PubMed Web of Science ®Google Scholar
• Goldstein H. The reported demography and causes of blindness throughout the world. Adv Ophthalmol. 1980;40:1–99.
   PubMedGoogle Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236. doi:10.1159/000078612.
   PubMed Web of Science ®Google Scholar
• Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol. 1962;68:502–514. doi:10.1001/archopht.1962.00960030506014.
   PubMed Web of Science ®Google Scholar
• Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the pacific ocular inflammation study. JAMA Ophthalmology. 2013;131(11):1405–1412. doi:10.1001/jamaophthalmol.2013.4237.
   PubMed Web of Science ®Google Scholar
• Gritz DC, Wong IG. Incidence and prevalence of uveitis in northern california; the northern california epidemiology of uveitis study. Ophthalmology. 2004;111(3):491–500. doi:10.1016/j.ophtha.2003.06.014.
   PubMed Web of Science ®Google Scholar
• Suhler EB, Lloyd MJ, Choi D, Rosenbaum JT, Austin DF. Incidence and prevalence of uveitis in veterans affairs medical centers of the Pacific Northwest. Am J Ophthalmol. 2008;146(6):890–896. e898. doi:10.1016/j.ajo.2008.09.014.
   PubMed Web of Science ®Google Scholar
• Bro T, Tallstedt L. Epidemiology of uveitis in a region of southern Sweden. Acta Ophthalmol. 2020;98(1):32–35. doi:10.1111/aos.14130.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513. doi:10.1016/S0002-9394(00)00659-0.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Altaweel MM, Holbrook JT, et al. Writing committee for the multicenter uveitis steroid treatment (MUST) trial and follow-up study research group, Kempen JH, et al. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, Posterior, or Panuveitis. JAMA. 2017;317(19):1993–2005. doi:10.1001/jama.2017.5103.
   PubMed Web of Science ®Google Scholar
• Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332–336. doi:10.1136/bjo.80.4.332.
   PubMed Web of Science ®Google Scholar
• Cameron AR, Morrison VL, Levin D, et al. Anti-Inflammatory effects of metformin irrespective of diabetes status. Circ Res. 2016;119(5):652–665. doi:10.1161/CIRCRESAHA.116.308445.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Manola A, Murakami Y, et al. Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2011;52(9):6565–6571. doi:10.1167/iovs.11-7331.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Yoshimura T, Simeonova M, et al. Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2012;53(7):4158–4169. doi:10.1167/iovs.11-9323.
   PubMed Web of Science ®Google Scholar
• Nasri H, Metformin: R-KM. Current knowledge. J Res Med Sci. 2014;19:658–664.
   PubMed Web of Science ®Google Scholar
• Sobrin L, Yu Y, Susarla G, et al. Risk of Non-infectious Uveitis with female hormonal therapy in a large healthcare claims database. Ophthalmology 2020;127:1558–1566.
   Google Scholar
• Young BA, Lin E, Von Korff M, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14(1):15–23.
   PubMed Web of Science ®Google Scholar
• Desai RJ, Eddings W, Liao KP, Solomon DH, Kim SC. Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken). 2015;67(4):457–466. doi:10.1002/acr.22483.
   PubMed Web of Science ®Google Scholar
• Stein JD, Blachley TS, Musch DC. Identification of persons with incident ocular diseases using health care claims databases. Am J Ophthalmol. 2013;156(6):1169–1175. e1163. doi:10.1016/j.ajo.2013.06.035.
   PubMed Web of Science ®Google Scholar
• Sobrin L, Stanwyck LK, Pan W, Hubbard RA, Kempen JH, VanderBeek BL. Association of Hypovitaminosis D with increased risk of uveitis in a large health care claims database. JAMA Ophthalmol. 2018;136(5):548–552. doi:10.1001/jamaophthalmol.2018.0642.
   PubMed Web of Science ®Google Scholar
• Forooghian F, Maberley D, Albiani DA, Kirker AW, Merkur AB, Etminan M. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study. Ocul Immunol Inflamm. 2013;21(5):390–393. doi:10.3109/09273948.2013.808351.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Heagerty PJ. Partly conditional survival models for longitudinal data. Biometrics. 2005;61(2):379–391. doi:10.1111/j.1541-0420.2005.00323.x.
   PubMed Web of Science ®Google Scholar
• Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189–2194. doi:10.1056/NEJMsr077003.
   PubMed Web of Science ®Google Scholar
• Gejjalagere Honnappa C, Mazhuvancherry Kesavan U. A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: an emerging target. Int J Immunopathol Pharmacol. 2016;29(4):562–571. doi:10.1177/0394632016673369.
   PubMed Web of Science ®Google Scholar
• Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355(23):2427–2443. doi:10.1056/NEJMoa066224.
   PubMed Web of Science ®Google Scholar
• Bearelly S, Mruthyunjaya P, Tzeng JP, et al. Identification of patients with diabetic macular edema from claims data: a validation study. Arch Ophthalmol. 2008;126(7):986–989. doi:10.1001/archopht.126.7.986.
   PubMed Web of Science ®Google Scholar
• Muir KW, Gupta C, Gill P, Stein JD. Accuracy of international classification of diseases, ninth revision, clinical modification billing codes for common ophthalmic conditions. JAMA Ophthalmol. 2013;131(1):119–120. doi:10.1001/jamaophthalmol.2013.577.
   PubMed Web of Science ®Google Scholar
• Goto M, Ohl ME, Schweizer ML, Perencevich EN. Accuracy of administrative code data for the surveillance of healthcare-associated infections: a systematic review and meta-analysis. Clin Infect Dis. 2014;58(5):688–696. doi:10.1093/cid/cit737.
   PubMed Web of Science ®Google Scholar
• Santos CA, Brennan DC, Olsen MA. Accuracy of Inpatient International Classification of Diseases, Ninth Revision, Clinical Modification Coding for Cytomegalovirus After Kidney Transplantation. Transplant Proc. 2015;47(6):1772–1776. doi:10.1016/j.transproceed.2015.04.087.
   PubMed Web of Science ®Google Scholar